Creative Edge Nutrition Inc (FITX)

[end user]

LP's under ACMPR


What it means for licensed producers

Part 1 of the ACMPR covers the permitted activities and general responsibilities of licensed producers, including:

requirements to obtain and maintain a licence
establishment and personnel security measures
authorized activities, including good production practices, packaging, shipping, labeling, import and export requirements, and record-keeping requirements
client registration and ordering requirements

Part 1 includes the requirements of the MMPR and the relevant section 56 CDSA exemptions that responded to the decision in R. v. Smith, enabling the production and sale of fresh marijuana and cannabis oil in addition to dried marijuana.

Newly-permitted activities under the ACMPR include the production and sale of starting materials (i.e., marijuana seeds and plants) to those individuals who have registered under Part 2 to produce a limited amount of cannabis for their own medical purposes or to have it produced by a designated person, and the ability to sell an interim supply of fresh or dried marijuana or cannabis oil to registered persons while they wait for their plants to grow.

Licences and licence applications under the ACMPR consolidate the MMPR licence requirements for the production and sale of dried marijuana, the requirements for supplemental licences under the section 56 exemption, and the new requirements for the sale of marijuana seeds and plants.

Other notable changes from the MMPR include:

New labelling requirements for cannabis oil to include the carrier oil used and for cannabis oil in dosage form to include the number of capsules or units in the container, the net weight, and the volume of each capsule or unit
New labelling requirements for fresh and dried marijuana to include the percentage of THC and CBD that could be yielded, taking into the account the potential to convert THC-Acid and CBD-Acid into THC and CBD
Provisions enabling individuals to receive their 30-day supply of cannabis within each 30-day period beginning on the date of the first sale
Modifying that the accuracy of weight and volume of products in packages must now be between 95% and 105%, as opposed to between 95% and 101%
Requiring all analytical testing to be done using validated methods (e.g., contaminants, disintegration, and solvent residue testing) and requiring disintegration testing for cannabis oil in capsules or similar dosage forms
Requiring notification to the Minister of Health prior to commencing a recall